MR. 7 SUPER 700000 capsules recall — Class I (D-0397-2026) · pharmaranks
Class IOngoing
MR. 7 SUPER 700000 capsules recall
FDA recall D-0397-2026 · initiated Dec 15, 2025
Most serious — a reasonable probability that use will cause serious harm or death.
Why it was recalled
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil
Details
Product
MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7
Recalling company
StuffbyNainax
Classification
Class I
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Product was distributed to 4 customers in the US.
Initiated
Dec 15, 2025
FDA report date
Mar 11, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.